RNA5SP464

Across TCGA pan-cancer cohorts, RNA5SP464 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNA5SP464 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNA5SP464 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNA5SP464 expression acts as an unfavorable survival marker, although some lineages such as PAAD and KIRP show a favorable association.

PAAD, KIRC, and OV are the cancer types where RNA5SP464 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.495	0.306	.003	69	view →
KIRC	DFS	Median	All	0.534	0.703	<.001	40	view →
OV	OS	Quartile	IV	0.549	0.804	.001	34	view →
KIRP	OS	Tertile	III,IV	0.847	0.240	.013	28	view →
BLCA	DFS	Tertile	IV	0.474	0.308	.025	26	view →
SKCM	OS	Tertile	III,IV	0.593	0.341	.004	21	view →
ACC	DFS	Tertile	III,IV	0.077	0.462	.002	21	view →
UCS	OS	Tertile	IV	0.844	0.250	.016	18	view →
SARC	DFS	Tertile	All	0.432	0.634	.020	15	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	9	view →
CHOL	OS	Tertile	All	1.000	0.350	.032	9	view →
THCA	DFS	Tertile	III,IV	0.755	0.879	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RNA5SP464–PAAD (DFS)

Open the PAAD breakdown →